Impact of policy change on US Army combat transfusion practices

John W Simmons1, Christopher E White, Brian J Eastridge

  • 1United States Army Institute of Surgical Research, Fort Sam Houston, Texas 78234, USA. john.simmons@amedd.army.mil

The Journal of Trauma
|July 13, 2010
PubMed

Insights

The US Army's damage control resuscitation clinical practice guideline (CPG) improved transfusion practices for combat-wounded patients, leading to higher plasma to red blood cell ratios and less crystalloid use.

Area of Science:

  • Trauma Surgery
  • Resuscitation Medicine
  • Military Medicine

Background:

  • Clinical practice guidelines (CPGs) aim to update providers and guide decision-making, but their impact can be limited.
  • In 2006, the US Army implemented a damage control resuscitation CPG, advocating for 1:1 plasma to red blood cell (RBC) ratios and restricted crystalloid use.

Purpose of the Study:

  • To evaluate the association between the 2006 US Army damage control resuscitation CPG and changes in transfusion practices for combat-wounded patients.

Main Methods:

  • A retrospective analysis of US service members who received massive transfusions (≥10 RBC units/24h) during Operation Iraqi Freedom/Operation Enduring Freedom.
  • Patients were divided into pre- and post-CPG cohorts, comparing fresh frozen plasma (FFP):RBC ratios and crystalloid volumes.

Main Results:

  • The post-CPG cohort (n=777) exhibited significantly higher FFP:RBC ratios (0.8 vs. 0.5) and reduced crystalloid administration (9 L vs. 14 L) compared to the pre-CPG cohort.
  • Post-CPG patients presented with higher body temperatures and received more RBC, platelets, and plasma.
  • No significant difference in overall mortality was observed between the two cohorts (19% vs. 24%).

Conclusions:

  • Implementation of the damage control resuscitation CPG was associated with a significant shift towards higher FFP:RBC ratios and decreased crystalloid use in combat casualties.
  • These practice changes align with damage control resuscitation principles, potentially influenced by battlefield maturity and product availability.
  • Patients in the post-CPG cohort presented with improved physiological parameters, including normothermia and higher hemoglobin levels.
Abstract

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...